Get the latest tech news
FDA approves AI-powered DermaSensor for enhanced skin cancer evaluation
Discover the FDA-approved DermaSensor, an AI-powered device revolutionizing skin cancer detection for patients over 40.
While DermaSensor offers a more accurate assessment of skin lesions, it is important to note that it is not intended as a standalone diagnostic tool or a screening device. This testing aims to ensure its effectiveness across diverse demographic groups representative of the U.S. population, including those with a relatively low incidence of melanoma, who were underrepresented in the premarket studies. For healthcare providers, particularly those who are not dermatologists, DermaSensor offers a valuable tool in the early detection of skin cancer, potentially leading to timely and life-saving interventions.
Or read this on ReadWrite